Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar;34(2):e14871.
doi: 10.1111/dth.14871. Epub 2021 Feb 19.

Pemphigus vulgaris flare in a patient treated with nivolumab

Rebecca C Clawson  1 , Mika M Tabata  2 , Steven T Chen  3
Affiliations
Case Reports

Pemphigus vulgaris flare in a patient treated with nivolumab

Rebecca C Clawson et al. Dermatol Ther. 2021 Mar.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Lopez AT, Khanna T, Antonov N, Audrey-Bayan C, Geskin L. A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors. Int J Dermatol. 2018;57(6):664-669. https://doi.org/10.1111/ijd.13984.
    1. Jour G, Glitza IC, Ellis RM, et al. Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions. J Cutan Pathol. 2016;43(8):688-696. https://doi.org/10.1111/cup.12717.
    1. Anastasopoulou A, Papaxoinis G, Diamantopoulos P, et al. Bullous pemphigoid-like skin lesions and overt eosinophilia in a patient with melanoma treated with nivolumab: case report and review of the literature. J Immunother. 2018;41(3):164-167. https://doi.org/10.1097/CJI.0000000000000210.
    1. Aggarwal P. Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system. Expert Opin Drug Saf. 2019;18(7):623-633. https://doi.org/10.1080/14740338.2019.1619693.
    1. Chen W-S, Tetzlaff MT, Diwan H, et al. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: a spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. J Cutan Pathol. 2018;45(10):764-773. https://doi.org/10.1111/cup.13312.

LinkOut - more resources